Francisco, Lyka D.
HRN: 22-45-57 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2023
CEFTRIAXONE 1G (VIAL)
05/24/2023
05/30/2023
IV
4g
Q24
Sepsis
Waiting Final Action